Associate Professor Yoram Barak, Our People, Brain Health Research Centre

Associate Professor Yoram Barak's research interests include multiple sclerosis, cancer, a wide range of psychiatric conditions (such as depression, schizophrenia, and obsessive–compulsive disorder), old-age psychiatry, and suicide.

He is also interested in Alzheimer's Disease and has published a popular book called "Preventing Alzheimer's: A Personal Responsibility".

Find out more about Associate Professor Barak's research here.

Publications

Barak, Y., Sajjadi, S. F., Hobbs, L., & Patterson, T. (2024). Functional recovery in older adults with schizophrenia: A national interRAI study. International Journal of Social Psychiatry. Advance online publication. doi: 10.1177/00207640241230837

Taube, C., Mentzel, C., Glue, P., & Barak, Y. (2024). Aging of persons with schizophrenia: Analysis of a national dataset. International Psychogeriatrics, 36(1), 43-50. doi: 10.1017/S1041610223000145

Turner, R., Glue, P., & Barak, Y. (2023). The interRAI assessment for elder abuse: We can do better? Lessons from the Elder Abuse Prevention Fund project in New Zealand. Proceedings of the New Zealand Biostatistics Conference. Retrieved from https://events.otago.ac.nz/2023-biostatistics-conference

Patterson, T., Hobbs, L., Brown, E., & Barak, Y. (2023). Sexual assault in older-age adults: Criminal justice response in New Zealand. Journal of Aging & Social Policy. Advance online publication. doi: 10.1080/08959420.2023.2284575

Barak, Y., Taube, C., Mentzel, C., & Glue, P. (2023). Ageing of persons with schizophrenia: Analysis of a national data set. Australian & New Zealand Journal of Psychiatry, 57(Suppl. 1), (pp. 165). doi: 10.1177/00048674231169682

Copeland, B., Barak, Y., & Cheung, G. (2023). The 2023 New Zealand psychiatry of old age services and workforce survey. Australasian Psychiatry. Advance online publication. doi: 10.1177/10398562231180486

Mentzel, C., Taube, C., Glue, P., & Barak, Y. (2023). Older adults with schizophrenia and dementia: Analysis of a national dataset [Brief report]. Australasian Journal on Ageing, 42, 609-612. doi: 10.1111/ajag.13187

Barak, Y. (2023). Nutrition and mental health in the aging population. Frontiers in Psychiatry, 14, 1104762. doi: 10.3389/fpsyt.2023.1104762

Mentzel, C., Glue, P., Greco, P., & Barak, Y. (2023). Analysing realistic effects of modifiable risk factors for dementia in a large national dataset. Archives of Gerontology & Geriatrics, 105, 104852. doi: 10.1016/j.archger.2022.104852

Barak, Y., Greco, P., & Glue, P. (2023). Aging among persons with serious mental illness: Policy implications for earlier onset of frailty. GeroPsyc, 36(2), 92-96. doi: 10.1024/1662-9647/a000302

Barak, Y. (2022). Stress, distress, tensity, neuroticism, and risk of dementia [Invited]. JAMA Network Open, 5(12), e2247124. doi: 10.1001/jamanetworkopen.2022.47124

Barak, Y. (2022, November). What will 2023 look like for older adults? Verbal presentation at the Department of Psychological Medicine Research Day, Dunedin, New Zealand.

Barak, Y. (2022, September). Creating opportunities to improve detection of older adult abuse: A national interRAI study. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference, Queenstown, New Zealand.

Barak, Y. (2022). Clusters of dementia literacy: Implications from a survey of older adults. Australian & New Zealand Journal of Psychiatry, 56(Suppl. 1), (pp. 227). doi: 10.1177/00048674221088686

Hall, Y., Smith, J., Turner, R. M., Greco, P., Hau, K., & Barak, Y. (2022). Creating opportunities to improve detection of older adult abuse: A national interRAI study. BMC Geriatrics, 22, 220. doi: 10.1186/s12877-022-02938-3

Barak, Y. (2022). A Sisyphean task: Assessing suicide ideation. International Psychogeriatrics, 34(5), 411-412. doi: 10.1017/S1041610222000114

Chacko, E., Ling, B., Avny, N., Barak, Y., Cullum, S., Sundram, F., & Cheung, G. (2022). Mindfulness-based cognitive therapy for stress reduction in family carers of people living with dementia: A systematic review. International Journal of Environmental Research & Public Health, 19(1), 614. doi: 10.3390/ijerph19010614

Barak, Y., Rapsey, C., & Scott, K. M. (2022). Clusters of dementia literacy: Implications from a survey of older adults. Journal of Prevention of Alzheimer's Disease, 1(9), 172-177. doi: 10.14283/jpad.2021.66

Barak, Y., Fortune, S., Hobbs, L., Cheung, G., Johari, N., & Zalsman, G. (2022). Strategies to prevent elderly suicide: A Delphi consensus study. Australasian Psychiatry, 30(3), 298-302. doi: 10.1177/10398562211064256

Barak, Y. (2021, July). Internalising disorders and dementia risk. Verbal presentation at the Brain Health Research Centre (BHRC) Annual Conference, Dunedin, New Zealand.

Cheung, G., Barak, Y., & Fortune, S. (2021, September). Strategies to prevent elderly suicide: A Delphi consensus study. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Scientific Conference, Queenstown, New Zealand.

Speciani, M., Barak, Y., Damanhuri, H., De Ronchi, D., Panariello, F., & Atti, A. R. (2021). A perspective on chronic and long-lasting anorexia nervosa. Frontiers in Psychiatry, 12, 756669. doi: 10.3389/fpsyt.2021.756669

Cheung, G., Maher, T. M., Barak, Y., & Hirdes, J. P. (2021). Determinants of non-emergency use of control interventions in older Canadian psychiatric inpatients: Analysizing the interRAI mental health electronic health records. Frontiers in Psychiatry, 12, 744341. doi: 10.3389/fpsyt.2021.744341

Barak, Y., Barson, D., Davie, G., Glue, P., & Paleacu, D. (2021). Internalize at your peril: Internalizing disorders as risk factors for dementia: Cohort study. GeroScience, 43, 253-261. doi: 10.1007/s11357-020-00285-y

Thomson, W. M., & Barak, Y. (2021). Tooth loss and dementia: A critical examination. Journal of Dental Research, 100(3), 226-231. doi: 10.1177/0022034520957233

Barak, Y., Leitch, S., & Glue, P. (2021). The Great Escape: Centenarians' exceptional health. Aging Clinical & Experimental Research, 33(3), 513-520. doi: 10.1007/s40520-020-01552-w

Barak, Y. (2020, November). Internalizing disorders as risk factors for dementia: A cohort study. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: A Climate for Change: Nga Tohu Huarere e panoni haere nei, he ao hurihuri, Napier, New Zealand.

Barak, Y. (2020, November). Ageing badly: Indicators of old age structure in Australia and New Zealand. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: A Climate for Change: Nga Tohu Huarere e panoni haere nei, he ao hurihuri, Napier, New Zealand.

Barak, Y. (2020, November). Older adults abuse: Analysis of a New Zealand national dataset. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: A Climate for Change: Nga Tohu Huarere e panoni haere nei, he ao hurihuri, Napier, New Zealand.

Chacko, E., Ling, B., Avny, N., Barak, Y., Cullum, S., . . ., & Cheung, G. (2020). Mindfulness based cognitive therapy (MBCT) for family dementia carers: A systematic review. Proceedings of the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: A Climate for Change: Nga Tohu Huarere e panoni haere nei, he ao hurihuri. Retrieved from https://www.ranzcp2020.co.nz

Hall, Y., Greco, P., Hau, K., & Barak, Y. (2020). Older adults abuse: Analysis of a New Zealand national dataset [Brief report]. International Psychogeriatrics, 32(8), 1003-1008. doi: 10.1017/s1041610220001520

Barak, Y., Neehoff, S., & Glue, P. (2020). Ageing badly: Indicators of old-age structure in Australia and New Zealand. Journal of Primary Health Care, 12(3), 272-276. doi: 10.1071/hc19095

Moebs, I., Abeln, E., Siefert, A., & Barak, Y. (2020). Potentially inappropriate medications in a psychogeriatric inpatient ward: An audit based on Beers Criteria. Neurology & Therapy, 9, 151-157. doi: 10.1007/s40120-020-00188-2

Barak, Y., & Glue, P. (2020). Progesterone loading as a strategy for treating postpartum depression [Short communication]. Human Psychopharmacology, 35, e2731. doi: 10.1002/hup.2731

Cheung, G., Barak, Y., & Hirdes, J. (2020). Rates and determinants of emergency and non-emergency control interventions use in older psychiatric inpatients in Ontario, Canada. Proceedings of the World interRAI Conference. (pp. 33). Retrieved from https://kuleuvencongres.be/worldinterRAI2020/home

Barak, Y., Cheung, G., Fortune, S., & Glue, P. (2020). No country for older men: Ageing male suicide in New Zealand. Australasian Psychiatry, 28(4), 383-385. doi: 10.1177/1039856220905304

Barak, Y., Leitch, S., Greco, P., & Glue, P. (2020). Fatigue, sleep and depression: An exploratory interRAI study of older adults [Short communication]. Psychiatry Research, 284, 112772. doi: 10.1016/j.psychres.2020.112772

Barak, Y. (2020). Suicide ideation in US nursing homes: Institutional freedom versus institutional paternalism. American Journal of Geriatric Psychiatry, 28(3), 299-301. doi: 10.1016/j.jagp.2019.12.012

Gale, C., & Barak, Y. (2020). Euthanasia, medically assisted dying or assisted suicide: Time for psychiatrists to say no. Australasian Psychiatry, 28(2), 160-163. doi: 10.1177/1039856219878645

Barak, Y., Gray, A. R., Rapsey, C., & Scott, K. (2020). The Dunedin Dementia Risk Awareness Project: Pilot study in older adults. International Psychogeriatrics, 32(2), 241-254. doi: 10.1017/s1041610219000772

Glue, P., & Barak, Y. (2019). Progesterone loading as a strategy for treating post-partum depression. Proceedings of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference. Retrieved from https://www.ranzcp2019.co.nz

Barak, Y., Leitch, S., Gale, C., & Glue, P. (2019). No seasonal influence on cognitive performance in a national sample of older adults in New Zealand [Brief report]. Australasian Journal on Ageing, 29, e201-e204. doi: 10.1111/ajag.12733

Cheung, G., Wright-St Clair, V., Chacko, E., & Barak, Y. (2019). Financial difficulty and biopsychosocial predictors of loneliness: A cross-sectional study of community dwelling older adults. Archives of Gerontology & Geriatrics, 85, 103935. doi: 10.1016/j.archger.2019.103935

Choo, T., Barak, Y., & East, A. (2019). The effects of intuitive movement reembodiment on the quality of life of older adults with dementia: A pilot study. American Journal of Alzheimer's Disease & Other Dementias, 35, 1-7. doi: 10.1177/1533317519860331

Barak, Y., & Gale, C. (2019). Suicide in long-term care facilities: The exception or the norm? [Invited]. JAMA Network Open, 2(6), e195634. doi: 10.1001/jamanetworkopen.2019.5634

Shelef, A., Brafman, D., Rosing, T., Weizman, A., Stryjer, R., & Barak, Y. (2019). Equine assisted therapy for patients with post traumatic stress disorder: A case series study [Brief report]. Military Medicine, 184(9/10), 394-399. doi: 10.1093/milmed/usz036

Johari, N., Glue, P., & Barak, Y. (2019). Screaming behaviour in response to electroconvulsive treatment: Psychogeriatric note on a patient with Alzheimer's disease. Psychogeriatrics, 19, 626-627. doi: 10.1111/psyg.12443

Gale, C., Glue, P., & Barak, Y. (2019). Low-risk and high-risk groups matter in suicide risk. Psychological Medicine, 49(5), 879-880. doi: 10.1017/S0033291718003422

Barak, Y., Leitch, S., & Greco, P. (2019). Identifying hoarding disorder in the elderly using the interRAI. Archives of Gerontology & Geriatrics, 80, 95-97. doi: 10.1016/j.archger.2018.10.014

Aluzaite, K., Hyslop, B., Barak, Y., Brockway, B., Cutfield, N., & Schultz, M. (2018). Circadian lights in a hospital setting to improve sleep, recovery and decrease psychological distress in older adults. Proceedings of the Australian & New Zealand Society for Sarcopenia & Frality Research (ANZSSFR) Annual Meeting. (pp. 45). Retrieved from https://anzssfr.org/past-meetings

Leitch, S., Glue, P., Gray, A., Greco, P., & Barak, Y. (2018, November). Dynamics of loneliness in the elderly: Unlonely female centenarians. Verbal presentation at the Women’s Wellbeing Symposium, Dunedin, New Zealand.

Admiraal, A., Gale, C., Pollock, L., Bathgate, D., Glue, P., & Barak, Y. (2018). Refining medical students' risk assessment skills: Lifecycle scenarios. Proceedings of the Higher Education Development Centre (HEDC) Symposium: Celebrating Higher Education. (pp. 18). Retrieved from https://www.otago.ac.nz/hedc

Barak, Y., & Glue, P. (2018). Do social isolation and loneliness kill People with Alzheimer's disease? OBM Geriatrics, (2), 4. doi: 10.21926/obm.geriatr.1804021

Leitch, S., Glue, P., Gray, A. R., Greco, P., & Barak, Y. (2018). Comparison of psychosocial variables associated with loneliness in centenarian vs elderly populations in New Zealand. JAMA Network Open, 1(6), e183880. doi: 10.1001/jamanetworkopen.2018.3880

Barak, Y. (2018, March). Ageing well with a healthy brain. Verbal presentation at the Ageing Well Colloquium: Biological, Social, and Social Dimensions, Dunedin, New Zealand.

Aluzaite, K., Brockway, B., Barak, Y., Hyslop, B., Cutfield, N., & Schultz, M. (2018). Circadian lights in a hospital setting to improve sleep, recovery and decrease psychological distress: Study concept and pilot baseline assessment results. In K. Hillman (Ed.), Proceedings of the 36th International Australasian Winter Conference on Brain Research. (pp. 36). AWCBR. Retrieved from https://www.otago.ac.nz/awcbr

Barak, Y. (2018, August). The Holocaust and hypermnesia. Otago Memory Group, University of Otago, Dunedin, New Zealand. [Research Presentation].

Barak, Y. (2018, July). The Dunedin Dementia Risk Awareness Project: Pilot study in older adults. Hot Health: Focus on Wellness and Ageing, University of Otago, Dunedin, New Zealand. [Department Seminar].

Swartz-Vanetik, M., Zeevin, M., & Barak, Y. (2018). Scope and characteristics of suicide attempts among manic patients with bipolar disorder [Short report]. Crisis, 39(6), 489-492. doi: 10.1027/0227-5910/a000526

Glue, P., & Barak, Y. (2018). Prazosin for post-traumatic stress disorder. New England Journal of Medicine, 378(17), 1648-1650. doi: 10.1056/NEJMc1803171

Barak, Y., Rapsey, C., Fridman, D., & Scott, K. (2018). The Dunedin Dementia Risk Awareness Project: A convenience sample of general practitioners. New Zealand Medical Journal, 131(1474), 27-34. Retrieved from https://www.nzma.org.nz/journal

Ohana, I., Golander, H., & Barak, Y. (2018). Aging of Holocaust survivors: Discrepancies between subjective and general health in the greater Tel Aviv area. Israel Medical Association Journal, 20, 207-210.

Barak, Y. (2017, December). Creating a MCQs "bank" for psychological medicine. Verbal presentation at the Health Professional Education Research Symposium, Dunedin, New Zealand.

Barak, Y., & Fridman, D. (2017). Impact of Mediterranean diet on cancer: Focused literature review. Cancer Geonomics & Proteomics, 14(6), 403-408. doi: 10.21873/cgp.20050

Barak, Y. (2017, June). Preventing Alzheimer's disease. Invited presentation at the Southern Health Symposium, Dunedin, New Zealand.

Tzvieli, A., Zaig, T., Ayal, I., Thieberger, G., Rothschild, S., & Barak, Y. (2017). The impact of self-directed Voice of Love messages on anger: A pilot study. Advances in Mind-Body Medicine, 31(2), 12-15.

Croucher, M., Plopsky, I., Pridan, S., & Barak, Y. (2017). Treatment options for psychotic depression in older people: Focused literature review by New Zealand Psychogeriatric Team. Annals of Psychiatry & Mental Health, 5(1), 1094.

Briskman, I., Shelef, A., Berger, U., Baruch, Y., Bar, G., Asherov, J., … Barak, Y. (2017). Deliberate self-harm in older adults: A general hospital emergency department survey. Israel Medical Association Journal, 19(3), 160-163.

Rothschild, S., Kaplan, G., Golan, T., & Barak, Y. (2017). Mindfulness meditation in the Israel Defense Forces: Effect on cognition and satisfaction with life: A randomized controlled trial. European Journal of Integrative Medicine, 10, 71-74. doi: 10.1016/j.eujim.2017.01.010

Barak, Y., Finkelstein, I., & Pridan, S. (2016). The geriatric mania asenapine study (GeMS). Archives of Gerontology & Geriatrics, 64, 111-114. doi: 10.1016/j.archger.2016.01.012

Shelef, A., Barak, Y., Berger, U., Paleacu, D., Tadger, S., Plopsky, I., & Baruch, Y. (2016). Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: An-open label, add-on, pilot study [Short communication]. Journal of Alzheimer's Disease, 51(1), 15-19. doi: 10.3233/jad-150915

Barak, Y., & Rothschild, S. (2016, October). Mindfulness meditation in the Israel defense forces: Effect on cognition and satisfaction with life. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists New Zealand Conference: Recover, Rebuild, Regenerate, Christchurch, New Zealand.

Shelef, A., Zdaka, C., & Barak, Y. (2015). Happiness amongst Israel Defense Force (IDF) Mental Health Officers (MHO’s). Disaster & Military Medicine, 1(7). doi: 10.1186/2054-314X-1-7

Pridan, S., Swartz, M., Baruch, Y., Tadger, S., Plopski, I., & Barak, Y. (2015). Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia. International Psychogeriatrics, 27(1), 131-134. doi: 10.1017/s1041610214001756

Achiron, A., Givon, U., Magalashvili, D., Dolev, M., Zaltzman, S. L., Kalron, A., … Barak, Y. (2015). Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study. Multiple Sclerosis Journal, 21(6), 767-775. doi: 10.1177/1352458514554053

Klang, S. H., Ben-Amnon, Y., Cohen, Y., & Barak, Y. (2015). Community pharmacists' support improves antidepressant adherence in the community. International Clinical Psychopharmacology, 30(6), 316-319. doi: 10.1097/yic.0000000000000090

Shelef, A., Mazeh, D., Berger, U., Baruch, Y., & Barak, Y. (2015). Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness. Journal of ECT, 31(2), 125-128. doi: 10.1097/yct.0000000000000197

Kertesz, D. P., Swartz, M. V., Tadger, S., Plopski, I., & Barak, Y. (2015). Tetrabenazine for tardive tremor in elderly adults: A prospective follow-up study. Clinical Neuropharmacology, 38(1), 23-25. doi: 10.1097/wnf.0000000000000061

Valencia, M., Fresán, A., Barak, Y., Juárez, F., Escamilla, R., & Saracco, R. (2015). Predicting functional remission in patients with schizophrenia: A cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome. Neuropsychiatric Disease & Treatment, 11, 2339-2348. doi: 10.2147/ndt.s87335

Nehama, Y., Rabinowitz, I., Baruch, Y., Mandel, A., Lurie, I., & Barak, Y. (2014). Debunking the placebo effect in depression: The effect of patient and investigator expectation on escitalopram efficacy. International Clinical Psychopharmacology, 29(2), 106-110. doi: 10.1097/yic.0000000000000013

Ohana, I., Golander, H., & Barak, Y. (2014). Balancing psychache and resilience in aging Holocaust survivors. International Psychogeriatrics, 26(6), 929-934. doi: 10.1017/s104161021400012x

Pridan, S., Baruch, Y., Swartz, M., & Barak, Y. (2014). Amisulpride for older patients with long-standing schizophrenia [Brief report]. Journal of Clinical Psychopharmacology, 34(6), 736-737. doi: 10.1097/jcp.0000000000000226

Raviv, G., Laufer, M., Baruch, Y., & Barak, Y. (2014). Risk of prostate cancer in patients with schizophrenia. Comprehensive Psychiatry, 55(7), 1639-1642. doi: 10.1016/j.comppsych.2014.05.007

Or, A., Baruch, Y., Tadger, S., & Barak, Y. (2014). Real-life decision making of Serious Mental Illness patients: Opt-in and opt-out research participation. Israel Journal of Psychiatry & Related Sciences, 51(3), 199-203.

Shelef, A., Hiss, J., Cherkashin, G., Berger, U., Aizenberg, D., Baruch, Y., & Barak, Y. (2014). Psychosocial and medical aspects of older suicide completers in Israel: A 10-year survey. International Journal of Geriatric Psychiatry, 29(8), 846-851. doi: 10.1002/gps.4070

Achiron, A., Chapman, J., Magalashvili, D., Dolev, M., Lavie, M., Bercovich, E., … Barak, Y. (2013). Modeling of cognitive impairment by disease duration in multiple sclerosis: A cross-sectional study. PLoS ONE, 8(8), e71058. doi: 10.1371/journal.pone.0071058

Bergman, Y., & Barak, Y. (2013). Escitalopram for antipsychotic nonresponsive visual hallucinosis: Eight patients suffering from Charles Bonnet syndrome. International Psychogeriatrics, 25(9), 1433-1436. doi: 10.1017/s1041610213000719

Baruch, Y., Tadger, S., Plopski, I., & Barak, Y. (2013). Asenapine for elderly bipolar manic patients [Brief report]. Journal of Affective Disorders, 145(1), 130-132. doi: 10.1016/j.jad.2012.05.027

Baruch, Y., Swartz, M., Sirkis, S., Mirecki, I., & Barak, Y. (2013). Staff happiness and work satisfaction in a tertiary psychiatric centre [Brief report]. Occupational Medicine, 63(6), 442-444. doi: 10.1093/occmed/kqt087

Barak, Y., & Aizenberg, D. (2012). Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment. BMC Psychiatry, 12, 108. doi: 10.1186/1471-244x-12-108

Barak, Y., & Swartz, M. (2012). Remission amongst elderly schizophrenia patients [Short communication]. European Psychiatry, 27(1), 62-64. doi: 10.1016/j.eurpsy.2010.12.012

Barak, Y., Levy, D., Szor, H., & Aizenberg, D. (2011). First-onset functional brief psychoses in the elderly. Canadian Geriatrics Journal, 14(2), 30-33.

Barak, Y., Plopski, I., Tadger, S., & Paleacu, D. (2011). Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: A randomized double-blind pilot study. International Psychogeriatrics, 23(9), 1515-1519. doi: 10.1017/s1041610211000743

Ohanna, I., Golander, H., & Barak, Y. (2011). Does late onset depression predispose to dementia? A retrospective, case-controlled study. Comprehensive Psychiatry, 52(6), 659-661. doi: 10.1016/j.comppsych.2010.10.016

Barak, Y., Swartz, M., & Baruch, Y. (2011). Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: A retrospective analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(7), 1744-1747. doi: 10.1016/j.pnpbp.2011.06.007

Barak, Y., & Aizenberg, D. (2011). Switching to aripiprazole as a strategy for weight reduction: A meta-analysis in patients suffering from schizophrenia. Journal of Obesity, 2011, 898013. doi: 10.1155/2011/898013

Levy, T. B., Barak, Y., Sigler, M., & Aizenberg, D. (2011). Suicide attempts and burden of physical illness among depressed elderly inpatients. Archives of Gerontology & Geriatrics, 52(1), 115-117. doi: 10.1016/j.archger.2010.02.012

Tadger, S., Paleacu, D., & Barak, Y. (2011). Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: A retrospective chart review. Archives of Gerontology & Geriatrics, 53(1), 104-105. doi: 10.1016/j.archger.2010.06.012

Barak, Y., & Aizenberg, D. (2010). Is dementia preventable? Focus on Alzheimer's disease. Expert Review of Neurotherapeutics, 10(11), 1689-1698. doi: 10.1586/ern.10.159

Briskman, I., Dubinski, R., & Barak, Y. (2010). Treating delirium in a general hospital: A descriptive study of prescribing patterns and outcomes. International Psychogeriatrics, 22(2), 328-331. doi: 10.1017/s1041610209990986

Barak, Y., Bleich, A., & Aizenberg, D. (2010). Psychosocial remission in schizophrenia: Developing a clinician-rated scale. Comprehensive Psychiatry, 51(1), 94-98. doi: 10.1016/j.comppsych.2008.11.013

Barak, Y., & Achiron, A. (2009). Happiness and neurological diseases. Expert Review of Neurotherapeutics, 9(4), 445-459. doi: 10.1586/ern.09.1

Mazeh, D., Bodner, E., Weizman, R., Delayahu, Y., Cholostoy, A., Martin, T., & Barak, Y. (2009). Co-morbid social phobia in schizophrenia. International Journal of Social Psychiatry, 55(3), 198-202. doi: 10.1177/0020764008093447

Abramowitz, E. G., Barak, Y., Ben-Avi, I., & Knobler, H. Y. (2008). Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: A randomized, Zolpidem-controlled clinical trial. International Journal of Clinical & Experimental Hypnosis, 56(3), 270-280. doi: 10.1080/00207140802039672

Rabinowitz, I., Baruch, Y., & Barak, Y. (2008). High-dose escitalopram for the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacology, 23(1), 49-53. doi: 10.1097/YIC.0b013e3282f0f0c5

Wohl, Y., Aviv, A., Friedman, T., & Barak, Y. (2008). Cutaneous photodamage in schizophrenia patients. Photodermatology, Photoimmunology & Photomedicine, 24(6), 291-295. doi: 10.1111/j.1600-0781.2008.00378.x

Barak, Y. (2008). Co-prescription of antidepressants with other psychotropics: Distinct profile of escitalopram. International Journal of Psychiatry in Clinical Practice, 12(1), 31-35. doi: 10.1080/13651500701419701

Barak, Y. (2008). Breast cancer in women suffering from serious mental illness. Schizophrenia Research, 102(1-3), 249-253. doi: 10.1016/j.schres.2008.03.017

Werner, P., Aviv, A., & Barak, Y. (2008). Self-stigma, self-esteem and age in persons with schizophrenia. International Psychogeriatrics, 20(1), 174-187. doi: 10.1017/s1041610207005340

Paleacu, D., Barak, Y., Mirecky, I., & Mazeh, D. (2008). Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: A 6-week, double-blind, placebo-controlled study. International Journal of Geriatric Psychiatry, 23(4), 393-400. doi: 10.1002/gps.1892

Mazeh, D., Paleacu, D., & Barak, Y. (2008). Quetiapine for elderly non-responsive schizophrenia patients [Brief report]. Psychiatry Research, 157(1-3), 265-267. doi: 10.1016/j.psychres.2007.06.015

Simeoni, M. C., Auquier, P., Fernandez, O., Flachenecker, P., Stecchi, S., Constantinescu, C. S., … Barak, Y., … on behalf of the MusiQoL study group. (2008). Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis Journal, 14(2), 219-230. doi: 10.1177/1352458507080733

Tadger, S., Baruch, Y., & Barak, Y. (2008). Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone. International Psychogeriatrics, 20(6), 1245-1250. doi: 10.1017/s1041610208007606

Barak, Y., Baruch, Y., Achiron, A., & Aizenberg, D. (2008). Suicide attempts of schizophrenia patients: A case-controlled study in tertiary care. Journal of Psychiatric Research, 42(10), 822-826. doi: 10.1016/j.jpsychires.2007.09.002

Harel, Y., Barak, Y., & Achiron, A. (2007). Dysregulation of affect in multiple sclerosis: New phenomenological approach. Psychiatry & Clinical Neurosciences, 61(1), 94-98. doi: 10.1111/j.1440-1819.2007.01616.x

Barak, Y., Baruch, Y., Mazeh, D., Paleacu, D., & Aizenberg, D. (2007). Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients. American Journal of Geriatric Psychiatry, 15(4), 354-356. doi: 10.1097/JGP.0b013e318030253a

Barak, Y. (2007). The aging of Holocaust survivors: Myth and reality concerning suicide. Israel Medical Association Journal, 9(3), 196-198.

Mazeh, D., Shahal, B., Aviv, A., Zemishlani, H., & Barak, Y. (2007). A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. International Clinical Psychopharmacology, 22(6), 371-375. doi: 10.1097/YIC.0b013e32817396ae

Barak, Y., Mazeh, D., Plopski, I., & Baruch, Y. (2006). Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. American Journal of Geriatric Psychiatry, 14(7), 629-633. doi: 10.1097/01.jgp.0000216325.42721.99

Friedman, T., Wohl, Y., Knobler, H. Y., Lubin, G., Brenner, S., Levi, Y., & Barak, Y. (2006). Increased use of mental health services related to Isotretinoin treatment: A 5-year analysis. European Neuropsychopharmacology, 16(6), 413-416. doi: 10.1016/j.euroneuro.2005.11.006

Barak, Y. (2006). The immune system and happiness. Autoimmunity Reviews, 5(8), 523-527. doi: 10.1016/j.autrev.2006.02.010

Mazeh, D., Zemishlani, H., Barak, Y., Mirecki, I., & Paleacu, D. (2006). Donepezil for negative signs in elderly patients with schizophrenia: An add-on, double-blind, crossover, placebo-controlled study. International Psychogeriatrics, 18(3), 429-436. doi: 10.1017/s1041610205003017

Barak, Y., & Achiron, A. (2006). Cognitive fatigue in multiple sclerosis: Findings from a two-wave screening project. Journal of the Neurological Sciences, 245(1-2), (pp. 73-6). doi: 10.1016/j.jns.2005.09.015

Achiron, A., & Barak, Y. (2006). Cognitive changes in early MS: A call for a common framework. Journal of the Neurological Sciences, 245(1-2), (pp. 47-51). doi: 10.1016/j.jns.2005.05.019

Barak, Y., & Aizenberg, D. (2006). Association between antidepressant prescribing and suicide in Israel. International Clinical Psychopharmacology, 21(5), 281-284.

Barak, Y., Olmer, A., & Aizenberg, D. (2006). Antidepressants reduce the risk of suicide among elderly depressed patients. Neuropsychopharmacology, 31(1), 178-181. doi: 10.1038/sj.npp.1300863

Aizenberg, D., Olmer, A., & Barak, Y. (2006). Suicide attempts amongst elderly bipolar patients. Journal of Affective Disorders, 91(1), 91-94. doi: 10.1016/j.jad.2005.12.013

Rotstein, Z., Hazan, R., Barak, Y., & Achiron, A. (2006). Perspectives in multiple sclerosis health care: Special focus on the costs of multiple sclerosis. Autoimmunity Reviews, 5(8), 511-516. doi: 10.1016/j.autrev.2006.02.001

Stein, D., Weizman, A., Ring, A., & Barak, Y. (2006). Obstetric complications in individuals diagnosed with autism and in healthy controls. Comprehensive Psychiatry, 47(1), 69-75. doi: 10.1016/j.comppsych.2005.01.001

Barak, Y., Aizenberg, D., Szor, H., Swartz, M., Maor, R., & Knobler, H. Y. (2005). Increased risk of attempted suicide among aging Holocaust survivors. American Journal of Geriatric Psychiatry, 13(8), 701-4. doi: 10.1176/appi.ajgp.13.8.701

Mazeh, D., Cholostoy, A., Zemishlani, C., & Barak, Y. (2005). Elderly psychiatric patients at risk of folic acid deficiency: A case controlled study. Archives of Gerontology & Geriatrics, 41(3), 297-302. doi: 10.1016/j.archger.2005.04.006

Stein, D., Zemishlani, C., Shahal, B., & Barak, Y. (2005). Disordered eating in elderly female patients diagnosed with chronic schizophrenia. Israel Journal of Psychiatry & Related Sciences, 42(3), 191-197.

Achiron, A., Polliack, M., Rao, S. M., Barak, Y., Lavie, M., Appelboim, N., & Harel, Y. (2005). Cognitive patterns and progression in multiple sclerosis: Construction and validation of percentile curves. Journal of Neurology, Neurosurgery & Psychiatry, 76(5), 744-749. doi: 10.1136/jnnp.2004.045518

Achiron, A., Barak, Y., Gail, M., Mandell, M., Pee, D., Ayyagari, R., & Rotstein, Z. (2005). Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Research & Treatment, 89(3), 265-270. doi: 10.1007/s10549-004-2229-4

Barak, Y., Swartz, M., & Plopsky, I. (2005). Assessing cardiovascular risks of olanzapine treatment: A 6-month study versus haloperidol in schizophrenia patients. International Clinical Psychopharmacology, 20(6), 315-317.

Barak, Y., Wohl, Y., Greenberg, Y., Dayan, Y. B., Friedman, T., Shoval, G., & Knobler, H. Y. (2005). Affective psychosis following Accutane (isotretinoin) treatment. International Clinical Psychopharmacology, 20(1), 39-41.

Barak, Y., Achiron, A., Mandell, M., Mirecki, I., & Aizenberg, D. (2005). Reduced cancer incidence among patients with schizophrenia. Cancer, 104(12), 2817-2821. doi: 10.1002/cncr.21574

Mazeh, D., Zemishlani, C., Aizenberg, D., & Barak, Y. (2005). Patients with very-late-onset schizophrenia-like psychosis: A follow-up study. American Journal of Geriatric Psychiatry, 13(5), 417-419. doi: 10.1176/appi.ajgp.13.5.417

Achiron, A., Kishner, I., Sarova-Pinhas, I., Raz, H., Faibel, M., Stern, Y., … Barak, Y. (2004). Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Archives of Neurology, 61(10), 1515-1520. doi: 10.1001/archneur.61.10.1515

Drimer, T., Shahal, B., & Barak, Y. (2004). Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. International Clinical Psychopharmacology, 19(1), 27-9. doi: 10.1097/01.yic.0000102048.1367.4c

Achiron, A., Edelstein, S., Ziev-Ner, Y., Givon, U., Rotstein, Z., & Barak, Y. (2004). Bone strength in multiple sclerosis: Cortical midtibial speed-of-sound assessment. Multiple Sclerosis, 10(5), 488-493. doi: 10.1191/1352458504ms1076oa

Barak, Y., Shamir, E., Mirecki, I., Weizman, R., & Aizenberg, D. (2004). Switching elderly chronic psychotic patients to olanzapine. International Journal of Neuropsychopharmacology, 7(2), 165-169. doi: 10.1017/s1461145703004048

Barak, Y., Knobler, C. Y., & Aizenberg, D. (2004). Suicide attempts amongst elderly schizophrenia patients: A 10-year case-control study. Schizophrenia Research, 71(1), 77-81. doi: 10.1016/j.schres.2003.12.001

Barak, Y., Cohen, A., & Aizenberg, D. (2004). Suicide among the homeless: A 9-year case-series analysis. Crisis, 25(2), 51-53. doi: 10.1027/0227-5910.25.2.51

Barak, Y., Mirecki, I., Knobler, H. Y., & Natan, Z. (2004). Suicidality and second generation antipsychotics in schizophrenia patients: A case-controlled retrospective study during a 5-year period. Psychopharmacology, 175(2), 215-219. doi: 10.1007/s00213-004-1801-2

Barak, Y., Davidson, M., Luxenberg, J. S., & Aizenberg, D. (2004). Psychiatric services in nursing homes in Israel: Should the American legislation be adopted? Israel Journal of Psychiatry & Related Sciences, 41(3), 213-217.

Remnik, Y., Melamed, Y., Swartz, M., Elizur, A., & Barak, Y. (2004). Patients' satisfaction with psychiatric inpatient care. Israel Journal of Psychiatry & Related Sciences, 41(3), 208-212.

Achiron, A., Barak, Y., & Rotstein, Z. (2003). Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis. Multiple Sclerosis, 9(5), 486-491. doi: 10.1191/1352458503ms945oa

Jeste, D. V., Barak, Y., Madhusoodanan, S., Grossman, F., & Gharabawi, G. (2003). International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. American Journal of Geriatric Psychiatry, 11(6), 638-647.

Mazeh, D., Melamed, Y., & Barak, Y. (2003). Emergency psychiatry: Treatment of referred psychiatric patients by general hospital emergency department physicians. Psychiatric Services, 54(9), 1221-1223. doi: 10.1176/appi.ps.54.9.1221

Barak, Y., & Aizenberg, D. (2003). Effects of olanzapine on lipid abnormalities in elderly psychotic patients. Drugs & Aging, 20(12), 893-896.

Hadjez, J., Stein, D., Gabbay, U., Bruckner, J., Meged, S., Barak, Y., … Rotenberg, V. S. (2003). Dream content of schizophrenic, nonschizophrenic mentally ill, and community control adolescents. Adolescence, 38(150), 331-342.

Mazeh, D., Mirecki, I., Paleacu, D., & Barak, Y. (2003). Donepezil for the treatment of a schizophrenia patient with frontal lobotomy. Journal of Clinical Psychopharmacology, 23(5), 522. doi: 10.1097/01.jcp.0000088913.24613.9f

Barak, Y., Aizenberg, D., & Achiron, A. (2003). Concordance for cognitive impairment: A study of 50 community-dwelling elderly female-female twin pairs. Comprehensive Psychiatry, 44(2), 117-120. doi: 10.1053/comp.2003.50019

Achiron, A., & Barak, Y. (2003). Cognitive impairment in probable multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 74(4), 443-446. doi: 10.1136/jnnp.74.4.443

Barak, Y., & Cohen, A. (2003). Characterizing the elderly homeless: A 10-year study in Israel. Archives of Gerontology & Geriatrics, 37(2), 147-155.

Achiron, A., Barak, Y., & Miron, S. (2003). Alfacalcidol treatment in multiple sclerosis. Clinical Neuropharmacology, 26(2), 53. [Letter].

Barak, Y., & Mashiach, M. (2003). Aggression: From basic science to real life. Israel Medical Association Journal, 5(9), 667-668.

Barak, Y., Swartz, M., Levy, D., & Weizman, R. (2003). Age-related differences in the side effect profile of citalopram. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27(3), 545-548. doi: 10.1016/s0278-5846(03)00041-1

Aizenberg, D., Weizman, A., & Barak, Y. (2003). Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients. Journal of Sex & Marital Therapy, 29(4), 297-303. doi: 10.1080/00926230390195533

Barak, Y., & Achiron, A. (2002). Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. European Neurology, 47(1), 11-14. doi: 10.1159/000047940

Paleacu, D., Mazeh, D., Mirecki, I., Even, M., & Barak, Y. (2002). Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease. Clinical Neuropharmacology, 25(6), 313-317.

Milstein, A., Pollack, A., Kleinman, G., & Barak, Y. (2002). Confusion/delirium following cataract surgery: An incidence study of 1-year duration. International Psychogeriatrics, 14(3), 301-306. doi: 10.1017/S1041610202008499

Aizenberg, D., Sigler, M., Weizman, A., & Barak, Y. (2002). Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study. International Psychogeriatrics, 14(3), 307-310.

Barak, Y., Lavie, M., & Achiron, A. (2002). Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test. Journal of Clinical Neuroscience, 9(6), 629-632. doi: 10.1054/jocn.2002.1110

Rotenberg, V. S., Shamir, E., Barak, Y., Indursky, P., Kayumov, L., & Mark, M. (2002). REM sleep latency and wakefulness in the first sleep cycle as markers of major depression: A controlled study vs. schizophrenia and normal controls. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26(6), 1211-1215. doi: 10.1016/S0278-5846(02)00216-6

Stein, D., Pat-Horenczyk, R., Blank, S., Dagan, Y., Barak, Y., & Gumpel, T. P. (2002). Sleep disturbances in adolescents with symptoms of attention-deficit/hyperactivity disorder. Journal of Learning Disabilities, 35(3), 268-275. doi: 10.1177/002221940203500308

Barak, Y., Shamir, E., & Weizman, R. (2002). Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study. Journal of Clinical Psychopharmacology, 22(2), 115-120.

Barak, Y., Aizenberg, D., Mirecki, I., Mazeh, D., & Achiron, A. (2002). Very late-onset schizophrenia-like psychosis: Clinical and imaging characteristics in comparison with elderly patients with schizophrenia. Journal of Nervous & Mental Disease, 190(11), 733-736. doi: 10.1097/01.nmd.0000038167.15155.d6

Nachman, R., Yanai, O., Goldin, L., Swartz, M., Barak, Y., & Hiss, J. (2002). Suicide in Israel: 1985-1997. Journal of Psychiatry & Neuroscience, 27(6), 423-428.

Barak, Y., & Aizenberg, D. (2002). Suicide amongst Alzheimer's disease patients: A 10-year survey. Dementia & Geriatric Cognitive Disorders, 14(2), 101-103. doi: 10.1159/000064931

Barak, Y., Shamir, E., Zemishlani, H., Mirecki, I., Toren, P., & Weizman, R. (2002). Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26(6), 1199-1202.

Barak, Y. (2002). No weight gain among elderly schizophrenia patients after 1 year of risperidone treatment. Journal of Clinical Psychiatry, 63(2), 117-119.

Shamir, E., Barak, Y., Shalman, I., Laudon, M., Zisapel, N., Tarrasch, R., … Weizman, R. (2001). Melatonin treatment for tardive dyskinesia: A double-blind, placebo-controlled, crossover study. Archives of General Psychiatry, 58(11), 1049-1052. doi: 10.1001/archpsyc.58.11.1049

Polliack, M. L., Barak, Y., & Achiron, A. (2001). Late-onset multiple sclerosis. Journal of the American Geriatrics Society, 49(2), 168-171. doi: 10.1046/j.1532-5415.2001.49038.x

Barak, Y., Bodner, E., Zemishlani, H., Mirecki, I., & Aizenberg, D. (2001). Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: A 6-month open trial. Archives of Gerontology & Geriatrics, 33(3), 237-241. doi: 10.1016/S0167-4943(01)00187-X

Stein, D., Ring, A., Shulman, C., Meir, D., Holan, A., Weizman, A., & Barak, Y. (2001). Brief report: Children with autism as they grow up: Description of adult inpatients with severe autism. Journal of Autism & Developmental Disorders, 31(3), 355-360.

Barak, Y., Savorai, O., Mavashev, S., & Beni, A. (2001). Animal-assisted therapy for elderly schizophrenic patients: A one-year controlled trial. American Journal of Geriatric Psychiatry, 9(4), 439-442. doi: 10.1097/00019442-200111000-00013

Barak, Y., Sirota, P., Kimhi, R., & Slor, H. (2001). Werner's syndrome (adult progeria): An affected mother and son presenting with resistant psychosis. Comprehensive Psychiatry, 42(6), 508-510. doi: 10.1053/comp.2001.27895

Barak, Y., Szor, H., Kimhi, R., Kam, E., Mester, R., & Elizur, A. (2001). Survey of patient satisfaction in adult psychiatric outpatient clinics. European Psychiatry, 16(2), 131-133. doi: 10.1016/S0924-9338(01)00551-X

Achiron, A., & Barak, Y. (2000). Multiple sclerosis: From probable to definite diagnosis: A 7-year prospective study. Archives of Neurology, 57(7), 974-979. doi: 10.1001/archneur.57.7.974

Shamir, E., Laudon, M., Barak, Y., Anis, Y., Rotenberg, V., Elizur, A., & Zisapel, N. (2000). Melatonin improves sleep quality of patients with chronic schizophrenia. Journal of Clinical Psychiatry, 61(5), 373-377.

Davidson, M., Harvey, P. D., Vervarcke, J., Gagiano, C. A., De Hooge, J. D., Bray, G., … Barak, Y., & Haushofer, M. (2000). A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. International Journal of Geriatric Psychiatry, 15(6), 506-514. doi: 10.1002/1099-1166(200006)15:6<506::AID-GPS146>3.0.CO;2-V

Barak, Y., & Szor, H. (2000). Lifelong posttraumatic stress disorder: Evidence from aging Holocaust survivors. Dialogues in Clinical Neuroscience, 2(1), 57-62.

Barak, Y., Kimhi, R., & Weizman, R. (2000). Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients? International Clinical Psychopharmacology, 15(1), 53-56.

Shamir, E., Barak, Y., Plopsky, I., Zisapel, N., Elizur, A., & Weizman, A. (2000). Is melatonin treatment effective for tardive dyskinesia? Journal of Clinical Psychiatry, 61(8), 556-558.

Keselbrener, L., Akselrod, S., Ahiron, A., Eldar, M., Barak, Y., & Rotstein, Z. (2000). Is fatigue in patients with multiple sclerosis related to autonomic dysfunction? Clinical Autonomic Research, 10(4), 169-175.

Achiron, A., Barak, Y., Miron, S., & Sarova-Pinhas, I. (2000). Immunoglobulin treatment in refractory Myasthenia gravis. Muscle & Nerve, 23(4), 551-555. doi: 10.1002/(SICI)1097-4598(200004)23:4<551::AID-MUS14>3.0.CO;2-O

Melamed, Y., Kimchi, R., & Barak, Y. (2000). Guardianship for the severely mentally ill. Medicine & Law, 19(2), 321-326.

Barak, Y., Bodner, E., Klayman, N., Ring, A., & Elizur, A. (2000). Anxiety among Israeli soldiers during the Gulf War. European Archives of Psychiatry & Clinical Neuroscience, 250(3), 148-151. doi: 10.1007/s004060070032

Melamed, Y., Fromer, D., Kemelman, Z., & Barak, Y. (2000). Working with mentally ill homeless persons: should we respect their quest for anonymity? Journal of Medical Ethics, 26(3), 175-178.

Swartz, M., Barak, Y., Mirecki, I., Naor, S., & Weizman, A. (2000). Treating depression in Alzheimer's disease: Integration of differing guidelines. International Psychogeriatrics, 12(3), 353-358.

Rotstein, Z., Barak, Y., Noy, S., & Achiron, A. (2000). Quality of life in multiple sclerosis: Development and validation of the 'RAYS' scale and comparison with the SF-36. International Journal for Quality in Health Care, 12(6), 511-517.

Dror, V., Shamir, E., Ghanshani, S., Kimhi, R., Swartz, M., Barak, Y., … Navon, R. (1999). hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Molecular Psychiatry, 4, 254-260.

Barak, Y., Gabbay, U., Gilad, R., Sarova-Pinhas, I., & Achiron, A. (1999). Neuropsychiatric assessment as a secondary outcome measure in a multiple sclerosis intravenous immunoglobulin L(IMg) trial. International Journal of Psychiatry in Clinical Practice, 3(1), 31-34. doi: 10.3109/13651509909024756

Barak, Y., Ur, E., & Achiron, A. (1999). Moclobemide treatment in multiple sclerosis patients with comorbid depression: An open-label safety trial. Journal of Neuropsychiatry & Clinical Neurosciences, 11(2), 271-273. doi: 10.1176/jnp.11.2.271

Levine, J., Barak, Y., Chengappa, K. R. N., Rapoport, A., Antelman, S. M., & Barak, V. (1999). Low CSF soluble interleukin 2 receptor levels in acute depression. Journal of Neural Transmission, 106(9-10), 1011-1015. doi: 10.1007/s007020050219

Achiron, A., Barak, Y., Noy, S., & Pinhas-Hamiel, O. (1999). Fluoxetine treatment for weight reduction in steroid-induced obesity: A pilot study in myasthenia gravis patients. European Neuropsychopharmacology, 9(1-2), 111-113. doi: 10.1016/S0924-977X(98)00012-1

Barak, Y., Wittenberg, N., Naor, S., Kutzuk, D., & Weizman, A. (1999). Clozapine in elderly psychiatric patients: Tolerability, safety, and efficacy. Comprehensive Psychiatry, 40(4), 320-325. doi: 10.1016/S0010-440X(99)90134-7

Barak, Y., Kimhi, R., Stein, D., Gutman, J., & Weizman, A. (1999). Autistic subjects with comorbid epilepsy: A possible association with viral infections. Child Psychiatry & Human Development, 29(3), 245-251.

Barak, Y., Lampl, Y., Sarova-Pinchas, I., & Achiron, A. (1998). Self and body esteem perception in multiple sclerosis. Behavioural Neurology, 11(3), 159-161.

Pinhas-Hamiel, O., Rotstein, Z., Achiron, A., Gabbay, U., Achiron, R., Barak, Y., … Noy, S. (1999). Pregnancy during residency: An Israeli survey of women physicians. Health Care for Women International, 20(1), 63-70. doi: 10.1080/073993399245962

Swartz, M., Martin, T., Martin, M., Elizur, A., & Barak, Y. (1999). Outcome of psychogeriatric intervention in an old-age home: a 3 years follow-up study. Annals of Clinical Psychiatry, 11(3), 109-112. doi: 10.1023/A:1022399608703

Achiron, A., Gabbay, U., Gilad, R., Hassin-Baer, S., Barak, Y., Gornish, M., … Sarova-Pinhas, I. (1998). Intravenous immunoglobulin treatment in multiple sclerosis: Effect on relapses. Neurology, 50(2), 398-402. doi: 10.1212/WNL.50.2.398

Pinhas-Hamiel, O., Barak, Y., Siev-Ner, I., & Achiron, A. (1998). Juvenile multiple sclerosis: clinical features and prognostic characteristics. Journal of Pediatrics, 132(4), 735-737. doi: 10.1016/S0022-3476(98)70371-3

Terno, P., Barak, Y., Hadjez, J., Elizur, A., & Szor, H. (1998). Holocaust survivors hospitalized for life: The Israeli experience. Comprehensive Psychiatry, 39(6), 364-367. doi: 10.1016/S0010-440X(98)90049-9

Melamed, Y., Szor, H., Barak, Y., & Elizur, A. (1998). Hoarding: What does it mean? Comprehensive Psychiatry, 39(6), 400-402.

Kimhi, R., Barak, Y., Gutman, J., Zohar, M., & Elizur, A. (1998). Forensic psychiatric service in Israel: Ten years experience in an in-patient hospital unit. Medicine & Law, 17(3), 393-399.

Levy, D., Kimhi, R., Barak, Y., Aviv, A., & Elizur, A. (1998). Antidepressant-associated mania: A study of anxiety disorders patients. Psychopharmacology, 136(3), 243-246. doi: 10.1007/s002130050562

Achiron, A., Barak, Y., Magal, N., Shohat, M., Cohen, M., Barar, R., & Gadoth, N. (1998). Abnormal liver test results in myotonic dystrophy. Journal of Clinical Gastroenterology, 26(4), 292-295.

Barak, Y., Swartz, M., Shamir, E., Stein, D., & Weizman, A. (1998). Vitamin E (α-tocopherol) in the treatment of tardive dyskinesia: A statistical meta-analysis. Annals of Clinical Psychiatry, 10(3), 101-105. doi: 10.1023/A:1022349920283

Achiron, A., Barak, Y., & Sarova-Pinhas, I. (1998). Use of intravenous immunoglobulin in multiple sclerosis. BioDrugs, 9(6), 465-475.

Barak, Y., Achiron, A., Rotstein, Z., Elizur, A., & Noy, S. (1998). Stress associated with asbestosis: The trauma of waiting for death. Psycho-Oncology, 7(2), 126-128. doi: 10.1002/(sici)1099-1611(199803/04)7:2<126::aid-pon291>3.0.co;2-a

Ring, A., Stein, D., Barak, Y., Teicher, A., Hadjez, J., Elizur, A., & Weizman, A. (1998). Sleep disturbances in children with attention-deficit/hyperactivity disorder: A comparative study with healthy siblings. Journal of Learning Disabilities, 31(6), 572-578. doi: 10.1177/002221949803100607

Kimhi, R., Barak, Y., Gutman, J., Melamed, Y., Zohar, M., & Barak, I. (1998). Police attitudes toward mental illness and psychiatric patients in Israel. Journal of the American Academy of Psychiatry & the Law, 26(4), 625-630.

Achiron, A., Rotstein, Z., Barak, Y., Sarova-Pinhas, I., for the MS Study Group. (1997). Intravenous immunoglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: The Israeli experience. Multiple Sclerosis, 3(2), 142-144. doi: 10.1177/135245859700300215

Levine, J., Aviram, A., Holan, A., Ring, A., Barak, Y., & Belmaker, R. H. (1997). Inositol treatment of autism. Journal of Neural Transmission, 104(2-3), 307-310. doi: 10.1007/bf01273191

Kimhi, R., Barak, Y., Achiron, A., & Elizur, A. (1997). Hepatitis among psychiatric inpatients: A high-risk group? International Journal of Risk & Safety in Medicine, 10(3), 207-210. doi: 10.3233/jrs-1997-10310

Lampl, Y., Barak, Y., Gilad, R., Eshel, Y., & Sarova-Pinhas, I. (1997). Familial dyslexia associated with cavum vergae. Clinical Neurology & Neurosurgery, 99(2), 142-147. doi: 10.1016/S0303-8467(97)80013-3

Achiron, A., Barak, Y., Stern, Y., & Noy, S. (1997). Electrical sensation during Tai-Chi practice as the first manifestation of multiple sclerosis. Clinical Neurology & Neurosurgery, 99(4), 280-281. doi: 10.1016/S0303-8467(97)00103-0

Kimhi, R., Barak, Y., Levy, D., & Elizur, A. (1997). Depression and anxiety as a single disorder: Evidence from brain stem auditory evoked potentials. European Psychiatry, 12(8), 395-398. doi: 10.1016/s0924-9338(97)83564-x

Levy, D., Kimhi, R., Barak, Y., Aviv, A., Pinhas-Hamiel, O., & Elizur, A. (1997). Acute neuroleptic induced leukopenia in Ethiopian Jews with benign familial leukopenia. International Journal of Risk & Safety in Medicine, 10(1), 27-30. doi: 10.3233/jrs-1997-10103

Barak, Y., Achiron, A., Elizur, A., Szor, H., & Shohat, B. (1997). Screening for Human T-cell Lymphotrophic Virus type-I (HTLV-I) infection in high risk schizophrenic patients. International Journal of Risk & Safety in Medicine, 10(3), 211-215. doi: 10.3233/jrs-1997-10311

Tishler, M., Barak, Y., Paran, D., & Yaron, M. (1997). Sleep disturbances, fibromyalgia and primary Sjögren's syndrome. Clinical & Experimental Rheumatology, 15(1), 71-74.

Achiron, A., Barak, Y., Goren, M., Gabbay, U., Miron, S., Rotstein, Z., … Sarova-Pinhas, I. (1996). Intravenous immune globulin in multiple sclerosis: Clinical and neuroradiological results and implications for possible mechanisms of action. Clinical & Experimental Immunology, 104 Suppl 1, 67-70.

Levine, J., Witztum, E., Greenberger, B. D., & Barak, Y. (1996). Inositol-induced mania? American Journal of Psychiatry, 153(6), 839. doi: 10.1176/ajp.153.6.839

Barak, Y., Levine, J., Glasman, A., Elizur, A., & Belmaker, R. H. (1996). Inositol treatment of Alzheimer's disease: A double blind, cross-over placebo controlled trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 20(4), 729-735. doi: 10.1016/0278-5846(96)00043-7

Barak, Y., Achiron, A., Kimhi, R., Lampl, Y., Gilad, R., Elizur, A., & Sarova-Pinhas, I. (1996). Health risks among shift workers: A survey of female nurses. Health Care for Women International, 17(6), 527-533.

Barak, Y., Ron, I. G., Sirota, P., Sobe, T., & Slor, H. (1996). The effect of chlorpromazine and haloperidol on DNA transcription. International Clinical Psychopharmacology, 11(3), 193-197.

Achiron, A., Pinhas-Hamiel, O., Barak, Y., Doll, L., Offen, C., Djaldetti, R., … Shohat, B. (1996). Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers. Archives of Virology, 141(1), 147-153. doi: 10.1007/BF01718595

Barak, Y., Levine, J., & Weisz, R. (1996). Clozapine-induced myoclonus: Two case reports. Journal of Clinical Psychopharmacology, 16(4), 339-340. [Letter].

Ticher, A., Ring, A., Barak, Y., Elizur, A., & Weizman, A. (1996). Circannual pattern of autistic births: Reanalysis in three ethnic groups. Human Biology, 68(4), 585-592.

Levy, D., Kimhi, R., Barak, Y., Demmer, M., Marel, M., & Elizur, A. (1996). Brainstem auditory evoked potentials of panic disorder patients. Neuropsychobiology, 33(3), 164-167. doi: 10.1159/000119269

Achiron, A., Barak, Y., Shohat, B., Gabbay, U., Elizur, A., Rotstein, Z., & Noy, S. (1996). Age distribution among patients at high risk for human T-cell lymphotrophic virus type I infection. Clinical Infectious Diseases, 22(5), 865-866.

Barak, Y., Achiron, A., Elizur, A., Gabbay, U., Noy, S., & Sarova-Pinhas, I. (1996). Sexual dysfunction in relapsing-remitting multiple sclerosis: Magnetic resonance imaging, clinical, and psychological correlates. Journal of Psychiatry & Neuroscience, 21, 255-258.

Kimhi, R., Barak, Y., Ring, A., Szor, H., & Elizur, A. (1995). Maintaining schizophrenic patients on benzodiazepines. Schizophrenia Research, 17(3), 283-285. doi: 10.1016/0920-9964(95)00054-2

Lampl, Y., Barak, Y., Achiron, A., & Sarova-Pinchas, I. (1995). Intracranial meningiomas: Correlation of peritumoral edema and psychiatric disturbances. Psychiatry Research, 58(2), 177-180.

Levine, J., Barak, Y., Kofman, O., & Belmaker, R. H. (1995). Follow-up and relapse analysis of an inositol study of depression. Israel Journal of Psychiatry & Related Sciences, 32(1), 14-21.

Barak, Y., Lampl, Y., Achiron, A., Sarova-Pinhas, I., & Elizur, A. (1995). Fluoxetine induced weight loss: A pilot study in postpartum women. Israel Journal of Psychiatry & Related Sciences, 32(1), 51-54.

Levine, J., Barak, Y., Gonzalves, M., Szor, H., Elizur, A., Kofman, O., & Belmaker, R. H. (1995). Double-blind, controlled trial of inositol treatment of depression. American Journal of Psychiatry, 152(5), 792-794. doi: 10.1176/ajp.152.5.792

Barak, Y., Ring, A., Levy, D., Granek, I., Szor, H., & Elizur, A. (1995). Disabling compulsions in 11 mentally retarded adults: An open trial of clomipramine SR. Journal of Clinical Psychiatry, 56(10), 459-461.

Barak, V., Barak, Y., Levine, J., Nisman, B., & Roisman, I. (1995). Changes in interleukin-1β and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. Journal of Basic & Clinical Physiology & Pharmacology, 6(1), 61-9. doi: 10.1515/JBCPP.1995.6.1.61

Barak, Y., Ring, A., Sulkes, J., Gabbay, U., & Elizur, A. (1995). Season of birth and autistic disorder in Israel. American Journal of Psychiatry, 152(5), 798-800. doi: 10.1176/ajp.152.5.798

Bodner, E., & Barak, Y. (1995). Visual perception in schizophrenic patients. European Psychiatry, 10(6), 320. doi: 10.1016/0924-9338(96)80315-4

Noy, S., Achiron, A., Gabbay, U., Barak, Y., Rotstein, Z., Laor, N., & Sarova-Pinhas, I. (1995). A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Comprehensive Psychiatry, 36(5), 390-395. doi: 10.1016/S0010-440X(95)90121-3

Barak, Y., Sirota, P., Tessler, M., Achiron, A., & Lampl, Y. (1994). Body esteem in Israeli university students. Israel Journal of Psychiatry & Related Sciences, 31(4), 292-295.

Sirota, P., Firer, M., Schild, K., Zurgil, N., Barak, Y., Elizur, A., & Slor, H. (1993). Increased anti-Sm antibodies in schizophrenic patients and their families. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 17(5), 793-800.

Ron, I. G., Inbar, M. J., Barak, Y., Stier, S., & Chaitchik, S. (1992). Organic delusional syndrome associated with tamoxifen treatment. Cancer, 69(6), 1415-1417. doi: 10.1002/1097-0142(19920315)69:6<1415::AID-CNCR2820690618>3.0.CO;2-H

Kashtan, H., Werbin, N., Aladjem, D., Barak, Y., & Wiznitzer, T. (1987). Right and left colon carcinoma: A retrospective comparative study. Journal of Surgical Oncology, 35(4), 245-248.

Are you looking for...

Are you looking for...

Are you looking for...

Are you looking for...

Are you looking for...

Are you looking for...

Are you looking for...

Publications